	2012 Mar 31	C 2013 Mar 31	2014 Mar 31	R 2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
	2012 Mar 31	C 2013 Mar 31	2014 Mar 31	R 2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M IR
EPS - Basic - ex Extraordinary Items	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5.20
Cost of Operating Revenue	149.25	180.57	215.84	241.23	207.96	189.33	196.57	237.75	241.09	334.62	306.94	400.85	445.90	452.81	493.44	463.76
EPS - Diluted - ex Extraordinary Items	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5.20
EBIT	9.35	21.19	29.68	24.61	23.34	27.69	22.04	37.67	38.04	72.41	76.92	45.28	67.99	58.56	60.46	44.64
EBITDA	21.15	33.65	42.60	36.88	31.45	36.01	30.56	46.41	47.62	82.60	88.02	58.00	80.90	74.15	77.94	63.63
EBITDA Margin	10.6	13.4	14.1	11.3	10.6	11.3	9.7	13.0	13.2	16.8	18.4	10.5	13.2	11.8	11.4	9.1
Supplementary
Financing Income/(Expense) - Net	-7.35	-10.41	-13.30	-7.05	-11.61	-13.70	-8.60	-8.52	-9.11	10.15	3.69	-9.84	-1.12	-6.73	-26.12	-
Gross Profit	49.65	69.65	87.00	84.50	88.36	129.37	118.14	120.15	118.41	157.19	170.59	150.13	168.69	176.79	187.98	-
Gross Margin	25.0	27.8	28.7	25.9	29.8	40.6	37.5	33.6	32.9	32.0	35.7	27.2	27.4	28.1	27.6	-
Profit before Taxes	5.34	11.12	17.18	-36.31	10.72	24.76	22.89	31.66	28.28	83.34	81.78	36.07	67.54	51.95	34.36	-
Profit after Tax	5.34	11.12	17.18	-39.12	10.72	19.91	20.49	24.02	21.02	61.61	61.03	27.23	50.96	38.55	25.73	-
PAT Margin	2.7	4.4	5.7	-12.0	3.6	6.2	6.5	6.7	5.8	12.5	12.8	4.9	8.3	6.1	3.8	-
Total Operating Expenses	189.56	229.03	273.17	301.12	272.98	291.02	292.67	320.23	321.46	419.41	400.60	505.70	546.61	571.05	620.96	-
Operating Profit	9.35	21.19	29.68	24.61	23.34	27.69	22.04	37.67	38.04	72.41	76.92	45.28	67.99	58.56	60.46	-
Operating Margin	4.7	8.5	9.8	7.6	7.9	8.7	7.0	10.5	10.6	14.7	16.1	8.2	11.1	9.3	8.9	-
Income Taxes	-	-	-	-	-	4.85	2.40	7.64	7.26	21.73	20.75	8.83	16.59	13.40	8.63	-
Total Revenue	198.90	250.22	302.85	325.73	296.32	318.71	314.71	357.90	359.50	491.81	477.52	550.99	614.59	629.60	681.42	-

Balance Sheet

Abridged

Understanding Balance Sheet

Kopran Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	C 2012 Mar 31	C 2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	R 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	C 2012 Mar 31	C 2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	R 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR
Total Assets	250.45	263.30	299.03	275.04	268.15	298.26	315.45	352.31	371.45	439.38	610.89	649.70	743.25	844.01	908.36
Total Shareholders' Equity	86.02	97.22	114.56	98.52	104.78	124.67	144.71	168.48	189.68	245.03	426.17	439.25	491.25	518.35	530.28
Total Current Liabilities	96.43	92.75	117.45	158.21	132.74	136.49	135.53	134.71	140.05	160.68	151.59	176.97	218.53	288.97	346.18
Accumulated Depreciation & Impairment	-	163.97	176.78	190.90	-	-	-	25.46	35.04	44.37	54.65	66.62	-	92.99	108.62
Long-Term Investments	0.81	0.81	0.81	0.11	0.05	0.05	0.05	0.02	0.02	0.05	0.06	0.06	0.06	0.06	0.06
Total Non-Current Liabilities	68.00	73.34	67.02	18.31	30.63	37.09	35.21	49.12	41.71	33.67	33.13	33.48	33.47	36.70	31.90
Long Term Debt	64.59	69.48	63.23	14.01	26.32	32.50	29.92	41.12	31.83	21.21	18.77	17.89	16.60	16.48	13.95
Property Plant & Equipment - Gross	-	292.32	301.43	293.68	-	-	-	154.98	167.88	190.73	230.20	285.10	-	389.95	448.00
Property Plant & Equipment - Net	133.23	128.35	124.65	102.78	103.60	109.15	111.70	129.53	132.84	146.36	175.55	218.48	256.69	296.96	339.37
Total Liabilities & Equity	250.45	263.30	299.03	275.04	268.15	298.26	315.45	352.31	371.45	439.38	610.89	649.70	743.25	844.01	908.36
Total Current Assets	106.54	122.61	159.70	169.98	152.77	179.72	193.50	207.57	222.60	276.95	414.87	399.07	454.03	509.75	523.18
Total Non-Current Assets	143.91	140.69	139.33	105.06	115.38	118.54	121.96	144.75	148.85	162.43	196.01	250.63	289.22	334.26	385.19
Total Liabilities	164.43	166.08	184.47	176.52	163.37	173.58	170.74	183.84	181.77	194.35	184.72	210.45	252.00	325.66	378.08
Total Equity	86.02	97.22	114.56	98.52	104.78	124.67	144.71	168.48	189.68	245.03	426.17	439.25	491.25	518.35	530.28

Cash Flow

Abridged

Understanding Cash Flow Statement

Kopran Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	C 2017 Mar 31	C 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	C 2017 Mar 31	C 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Capital Expenditures - Net	10.87	8.78	9.17	11.28	10.72	16.12	11.73	31.29	14.05	23.95	42.26	61.05	56.61	58.90	67.10
Dividends Paid - Cash - Total	0.36	-	-	-	-	-	-	-	-	6.49	6.49	14.46	14.46	14.46	14.49
Capital Expenditures - Gross	10.87	8.80	9.17	11.28	10.99	16.12	11.73	31.37	14.05	24.41	42.27	61.05	56.61	58.92	67.13
Working Capital - Increase/(Decrease)	10.88	-18.68	-40.32	8.58	-1.71	-33.13	-7.56	-15.59	-11.77	-23.79	-110.81	-5.55	-30.91	-21.56	12.33
Free Cash Flow to Equity	6.31	-5.87	0.92	-1.54	-0.54	2.18	2.47	-20.32	8.65	21.61	-71.27	-30.70	2.40	22.35	-6.51
Free Operating CF	14.33	-5.64	-20.19	22.22	5.37	-13.44	6.28	-14.62	8.18	29.62	-79.61	-31.38	-21.59	-26.07	-10.55
Free Operating CF net dividend	13.97	-5.64	-20.19	22.22	5.37	-13.44	6.28	-14.62	8.18	23.13	-86.10	-45.84	-36.06	-40.54	-25.03
Operating CF bef Changes in Working Cap	14.31	21.84	29.30	24.92	18.07	35.81	25.57	32.34	34.00	77.83	73.47	35.21	65.93	54.41	44.25
Debt - LT & ST - Issuance/(Retirement) - Total	-8.01	-0.26	21.11	-23.76	-6.18	15.62	-3.81	-5.79	0.47	-8.48	8.33	0.68	23.99	48.40	4.01
Stock - Issuance/(Retirement) - Net	-	-	-	-	-	-	-	-	-8.58	0.00	126.48	-	-	1.34	-
Net Cash Flow from Financing Activities	-8.37	-0.26	21.11	-23.91	-6.80	15.62	-6.50	8.20	-8.83	-28.36	128.01	-13.78	9.53	35.28	-10.47
Net CF from Investing Activities	-10.47	-9.47	-9.95	-9.82	-9.35	-18.41	-11.72	-24.97	-12.98	-24.70	-85.74	-14.35	-43.85	-56.75	-64.90
Net CF from Operating Activities	25.20	3.16	-11.02	33.50	16.36	2.67	18.01	16.75	22.23	54.04	-37.34	29.66	35.02	32.85	56.58

Business Segment Analysis

FY End:

Mar 26

Kopran Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

Pharmaceuticals business (100.0%)₹ 67.13 Cr

Revenue / Sales

Pharmaceuticals business (100.0%)₹ 681.42 Cr

Assets

Pharmaceuticals business (100.0%)₹ 908.36 Cr

Operating Income

Pharmaceuticals business (100.0%)₹ 60.46 Cr

Regional Segment Analysis

FY End:

Mar 26

Kopran Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales

India (33.8%)₹ 228.29 CrSouth Africa (18.7%)₹ 126.28 CrRest of World (18.4%)₹ 124.30 CrEthiopia (11.8%)₹ 79.82 CrBangladesh (4.9%)₹ 33.19 CrUnited Kingdom (2.6%)₹ 17.56 CrJordan (2.1%)₹ 14.13 CrRussia (1.7%)₹ 11.67 CrGermany (1.7%)₹ 11.44 CrMexico (1.3%)₹ 8.53 CrHong Kong (1.1%)₹ 7.13 CrTanzania (0.8%)₹ 5.69 CrSwitzerland (0.6%)₹ 3.74 CrZambia (0.4%)₹ 2.49 CrChile (0.2%)₹ 1.44 Cr

Historical Segment Analysis

Track how Kopran Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Pharmaceuticals business	14	24	42	61	57	59	67

Frequently Asked Questions

What is the revenue of Kopran Ltd.?

The latest trailing twelve month revenue of Kopran Ltd. is ₹ 547.75 Cr, reflecting a 1-year growth of -12.41% and a 3-year CAGR of 0.33%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Kopran Ltd.?

The latest trailing twelve month net profit (PAT) of Kopran Ltd. is ₹ 18.35 Cr, with a 3-year earnings CAGR of -1.92%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Kopran Ltd.?

The trailing twelve month EBITDA of Kopran Ltd. is approximately ₹ 48.57 Cr (based on an operating margin of 8.87%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Kopran Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Kopran Ltd. is 5.33. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Kopran Ltd.?

The debt-to-equity ratio of Kopran Ltd. stands at 0.29. The interest coverage ratio is 4.36x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Kopran Ltd.?

The estimated book value per share of Kopran Ltd. is 103.29 (derived from a P/B ratio of 2.38 and market price of ₹ 246.30), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Kopran Ltd.?

The trailing twelve month operating cash flow of Kopran Ltd. is ₹ 56.58 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Kopran Ltd. report consolidated or standalone financials?

Kopran Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.